Nonhormonal Hot Flash Pill Lynkuet Gets FDA Priority Review for Breast Cancer Patients on Hormone Therapy
The FDA granted priority review to Lynkuet for hot flashes caused by breast cancer endocrine therapy. Here is what the OASIS-4 trial showed.
Medical Daily ·